Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1997-9-25
pubmed:abstractText
The antibacterial properties of bismuth are greatly enhanced when bismuth is combined with certain lipophilic thiol compounds. Antibacterial activity was enhanced from 25- to 300-fold by the following seven different thiols, in order of decreasing synergy: 1,3-propanedithiol, dimercaprol (BAL), dithiothreitol, 3-mercapto-2-butanol, beta-mercaptoethanol, 1-monothioglycerol, and mercaptoethylamine. The dithiols produced the greatest synergy with bismuth at optimum bismuth-thiol molar ratios of from 3:1 to 1:1. The monothiols were generally not as synergistic and required molar ratios of from 1:1 to 1:4 for optimum antibacterial activity. The most-active mono- or dithiols were also the most soluble in butanol. The intensity of the yellow formed by bismuth-thiol complexes reflected the degree of chelation and correlated with antibacterial potency at high molar ratios. The bismuth-BAL compound (BisBAL) was active against most bacteria, as assessed by broth dilution, agar diffusion, and agar dilution analyses. Staphylococci (MIC, 5 to 7 microM Bi3+) and Helicobacter pylori (MIC, 2.2 microM) were among the most sensitive bacteria. Gram-negative bacteria were sensitive (MIC, < 17 microM). Enterococci were relatively resistant (MIC, 63 microM Bi3+). The MIC range for anaerobes was 15 to 100 microM Bi3+, except for Clostridium difficile (MIC, 7.5 microM). Bactericidal activity averaged 29% above the MIC. Bactericidal activity increased with increasing pH and/or increasing temperature. Bismuth-thiol solubility, stability, and antibacterial activity depended on pH and the bismuth-thiol molar ratio. BisBAL was stable but ineffective against Escherichia coli at pH 4. Activity and instability (reactivity) increased with increasing alkalinity. BisBAL was acid soluble at a molar ratio of greater than 3:2 and alkaline soluble at a molar ratio of less than 2:3. In conclusion, certain lipophilic thiol compounds enhanced bismuth antibacterial activity against a broad spectrum of bacteria. The activity, solubility, and stability of BisBAL were strongly dependent on the pH, temperature, and molar ratio. Chelation of bismuth with certain thiol agents enhanced the solubility and lipophilicity of this cationic heavy metal, thereby significantly enhancing its potency and versatility as an antibacterial agent.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-1396732, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-1854110, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-2305178, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-2406851, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-2406853, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-2406862, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-2566254, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-2682129, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-3079456, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-7310401, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-7651194, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-7667394, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-7968025, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-8487823, http://linkedlifedata.com/resource/pubmed/commentcorrection/9257744-8502272
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1697-703
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Enhancement of bismuth antibacterial activity with lipophilic thiol chelators.
pubmed:affiliation
Infectious Disease Division, Winthrop-Unversity Hospital, Mineola, New York 11501, USA.
pubmed:publicationType
Journal Article